Marianne de Backer, Chief Executive Officer at Vir Biotechnology, Inc. (VIR), sold 32,244 shares at $9.45 ($305K) on 2025-02-24, disclosed to the SEC on 2025-02-25.
Scheduled sale ($305k) by Chief Executive Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $9.45 | 16,122 | $152K | 50.0% |
| 2 | $9.45 | 16,122 | $152K | 50.0% |
| Total | $9.45 avg | 32,244 | $305K | 100% |
| Filing → |
| VIR | SELL | 2026-02-24 | $284K | — | Filing → |
| VIR | SELL | 2025-04-04 | $949K | — | Filing → |
| VIR | SELL | 2024-04-04 | $1.4M | — | Filing → |